Jasmine should not have begun data collection without IRB approval. She will need to discard any data collected prior to receiving approval and restart the study only after obtaining approval. Researchers cannot apply for retrospective approval or use data collected without approval.
This document provides an overview of the IRB approval process at James R. Galt's institution. It discusses why IRB approval is needed, what types of research require approval, and the key components of the IRB submission process, including study protocols, informed consent documents, and other approvals that may be required. It aims to help researchers understand the steps involved in obtaining IRB approval for their studies involving human subjects.
The document provides an introduction to the Institutional Review Board (IRB) at Bristol Community College. The IRB ensures that human subject research meets ethical standards by reviewing proposed studies. It describes the IRB's functions, past unethical studies that led to modern standards, the composition of IRB boards, types of research reviews, and the application process for obtaining IRB approval before beginning human subject research.
institutional review board and independent ethics committeeMOHAMMAD ASIM
The document discusses the role and responsibilities of institutional review boards (IRBs) in protecting human subjects in clinical research. It provides details on:
- The composition and quorum requirements of IRBs, including the need for diverse expertise and community representation.
- The functions of IRBs, which include reviewing research protocols, approving studies, overseeing informed consent processes, and ensuring ongoing ethical review of approved studies.
- The responsibilities of IRBs in evaluating risks and benefits to research participants, assessing payment amounts and methods, and requiring modifications or halting studies when necessary.
- The necessary components of informed consent forms used in clinical studies, including study details, risks/benefits, confidentiality
Research Ethics Committees (RECs- IRBs)Tamer Hifnawy
This document discusses the roles and functions of research ethics committees (RECs) and institutional review boards (IRBs). It provides an overview of when REC/IRB approval is required, the review process, and composition of RECs/IRBs. It also discusses interactions between IRBs in different countries and the roles of data safety monitoring boards. The document is authored by Dr. Tamer Hifnawy, an associate professor of public health in Egypt and Saudi Arabia who trains others in international research ethics.
The document summarizes the role and functions of the Human Research Ethics Committee (HREC) at Delft University of Technology. The HREC was established in 2012 to review all university research involving human subjects for ethical issues like informed consent and data privacy. It is chaired by Sabine Roeser and has seven members from various faculties. While ethics review is now common internationally, most European technical universities do not have such a committee. The HREC process involves submitting an application for either chair approval if minimal risk, or committee review. Applications have steadily increased and cover a range of research areas. The HREC checks for issues like safety certification, data collection methods, and informed consent forms. It aims to improve awareness and develop
Institutional review board by akshdeep sharmaAkshdeep Sharma
The Institutional Review Board/Independent Ethics Committee (IRB/IEC) serves as an independent body that reviews and approves clinical trials to protect participant safety and rights. The IRB/IEC consists of at least five members with diverse qualifications to evaluate scientific and ethical aspects of trials. The IRB/IEC's responsibilities include reviewing trials, providing continuing oversight, ensuring informed consent, and maintaining records for regulatory review.
Jasmine should not have begun data collection without IRB approval. She will need to discard any data collected prior to receiving approval and restart the study only after obtaining approval. Researchers cannot apply for retrospective approval or use data collected without approval.
This document provides an overview of the IRB approval process at James R. Galt's institution. It discusses why IRB approval is needed, what types of research require approval, and the key components of the IRB submission process, including study protocols, informed consent documents, and other approvals that may be required. It aims to help researchers understand the steps involved in obtaining IRB approval for their studies involving human subjects.
The document provides an introduction to the Institutional Review Board (IRB) at Bristol Community College. The IRB ensures that human subject research meets ethical standards by reviewing proposed studies. It describes the IRB's functions, past unethical studies that led to modern standards, the composition of IRB boards, types of research reviews, and the application process for obtaining IRB approval before beginning human subject research.
institutional review board and independent ethics committeeMOHAMMAD ASIM
The document discusses the role and responsibilities of institutional review boards (IRBs) in protecting human subjects in clinical research. It provides details on:
- The composition and quorum requirements of IRBs, including the need for diverse expertise and community representation.
- The functions of IRBs, which include reviewing research protocols, approving studies, overseeing informed consent processes, and ensuring ongoing ethical review of approved studies.
- The responsibilities of IRBs in evaluating risks and benefits to research participants, assessing payment amounts and methods, and requiring modifications or halting studies when necessary.
- The necessary components of informed consent forms used in clinical studies, including study details, risks/benefits, confidentiality
Research Ethics Committees (RECs- IRBs)Tamer Hifnawy
This document discusses the roles and functions of research ethics committees (RECs) and institutional review boards (IRBs). It provides an overview of when REC/IRB approval is required, the review process, and composition of RECs/IRBs. It also discusses interactions between IRBs in different countries and the roles of data safety monitoring boards. The document is authored by Dr. Tamer Hifnawy, an associate professor of public health in Egypt and Saudi Arabia who trains others in international research ethics.
The document summarizes the role and functions of the Human Research Ethics Committee (HREC) at Delft University of Technology. The HREC was established in 2012 to review all university research involving human subjects for ethical issues like informed consent and data privacy. It is chaired by Sabine Roeser and has seven members from various faculties. While ethics review is now common internationally, most European technical universities do not have such a committee. The HREC process involves submitting an application for either chair approval if minimal risk, or committee review. Applications have steadily increased and cover a range of research areas. The HREC checks for issues like safety certification, data collection methods, and informed consent forms. It aims to improve awareness and develop
Institutional review board by akshdeep sharmaAkshdeep Sharma
The Institutional Review Board/Independent Ethics Committee (IRB/IEC) serves as an independent body that reviews and approves clinical trials to protect participant safety and rights. The IRB/IEC consists of at least five members with diverse qualifications to evaluate scientific and ethical aspects of trials. The IRB/IEC's responsibilities include reviewing trials, providing continuing oversight, ensuring informed consent, and maintaining records for regulatory review.
This document outlines the roles and responsibilities of ethics committee (EC) members in reviewing clinical trial protocols. It describes the composition of ECs, which includes chairs, clinicians, scientists, legal experts, social scientists, philosophers, theologians, and lay people. The roles of EC members include scientifically and ethically reviewing protocols, informed consent documents, risks and benefits, qualifications, and providing ongoing trial oversight. The chair oversees meetings while the member secretary organizes documentation and communication. Together the multidisciplinary EC works to protect research participants.
The National Bioethics Committee (NBC) is an advisory body established by the Ministry of Health of Pakistan to deal with all aspects of bioethics in the health sector. The NBC aims to promote ethical health services, research, education, and medical journalism. It also oversees ethics review committees in various health organizations. The NBC upholds bioethical principles in healthcare and safeguards the rights and well-being of patients and research participants. It is responsible for the ethical review of research projects in Pakistan.
Institutional ethics committee : Roles and ResponsibilitiesDrSahilKumar
The document discusses the role and responsibilities of an Institutional Ethics Committee (IEC). The main points are:
1. An IEC is an independent body that reviews clinical trials and ensures the ethical treatment of human subjects. It evaluates protocols, informed consent forms, and other aspects of research proposals.
2. The IEC's main responsibilities are to protect participants, ensure universal ethical values are followed, and help develop research that meets local health needs.
3. The IEC reviews documents like protocols, consent forms, recruitment materials, safety information, and investigators' qualifications before research begins and conducts continuing annual reviews. It documents its approval, required modifications, or disapproval of proposed studies in writing.
The IRB/IEC is an independent body that reviews clinical trial protocols and protects participant rights and well-being. It consists of at least five qualified members from diverse backgrounds. The IRB/IEC reviews trials annually, ensures informed consent, and maintains documentation for regulatory review.
The document discusses the role and responsibilities of Institutional Review Boards (IRBs) and Independent Ethics Committees (IECs) in protecting human subjects in clinical research. IRBs/IECs review research protocols to evaluate scientific and ethical aspects and risks/benefits to participants. Their main purpose is to ensure the rights, safety, and well-being of trial subjects. IRBs/IECs must maintain documentation of their review procedures and activities.
The document discusses the basics of clinical research and clinical trials. It covers the key steps in drug discovery and development including target selection, validation, drug selection, optimization, pre-clinical and clinical testing. Clinical trials are systematic investigations in human subjects to evaluate safety and efficacy of new drugs, and are done in 4 phases. It takes approximately 10-12 years and $800 million to bring a new drug to market. Regulations, stakeholders, essential documents, and infrastructure requirements for clinical trials are also outlined.
Steps For Designing And Development Of Protocolpviral24
This document outlines the key sections and information to include when designing a clinical trial protocol. It discusses including background information on the investigational product, objectives, study design details, subject selection criteria, safety and efficacy assessments, data collection and management plans, statistical analysis methods, and other operational aspects like financing, publications, and records retention. The protocol is the detailed research plan that clinical trials are based on and it describes the rationale, structure, and procedures for the study.
Institutional ethics committee(IEC): A brief insight, by Rxvichu!!RxVichuZ
This is my 26th powerpoint.....its on INSTITUTIONAL ETHICS COMMITTEE(IEC) ...also known as RESEARCH and ETHICAL COMMITTEE(REC). It focusses on the general principles, that ought to be made, while selecting subjects for study.
Brief points, under specific headings, have been included.
Do go through this, and let me know your feedbacks.
Thank you!
Vishnu.
Suzanne Pozsonyi MedicReS World Congress 2013MedicReS
1. The document outlines the key study preparation and start up activities that are typically the responsibility of sponsors and CROs.
2. It discusses feasibility studies, site selection, pre-study visits, contracting, submitting documents to ethics committees, training, and initiation visits.
3. The purpose of these activities is to ensure clinical sites and investigators are properly qualified and prepared to conduct the study according to regulatory standards and the study protocol.
The document discusses the roles and responsibilities of ethics committees (ECs) or institutional review boards (IRBs). It states that ECs are independent bodies composed of medical, scientific, and non-scientific members who ensure the protection of human subjects in clinical trials. Their key responsibilities include reviewing and approving study protocols and informed consent documents. The document outlines that ECs should have a diverse membership including specialists in different areas like science, medicine, ethics, law, and lay persons. It explains the perspectives and expertise that different member types, such as basic scientists, legal experts, and social workers, provide to the EC. Finally, it states that the primary purpose of EC/IRB review is to assure the protection of subjects' rights
Clinical trial protocol, ammendments, Protocol deviations and violationsAmol Patil
This document provides guidelines for developing a clinical trial protocol including general information, background, aims and objectives, inclusion/exclusion criteria, study design, methodology, statistics, ethics, quality control, and protocol amendments. Key elements that must be addressed in the protocol are enumerated such as the research question, treatment characteristics, data collection and analysis, and legal responsibilities. Protocol deviations and violations that occur during the study are also discussed along with examples and regulatory requirements for reporting them. Adherence to good clinical practice and obtaining necessary approvals are emphasized.
Ethical committee-role, Principal InvestigatorGayathri Ravi
This document discusses ethics in research involving human subjects. It summarizes key landmark documents that guide ethical research, including the Nuremberg Code, Helsinki Declaration, and Belmont Report. It also describes the role and responsibilities of Institutional Review Boards (IRBs) in reviewing research proposals, ensuring risks are minimized and subjects' rights are protected, and providing ongoing oversight of approved studies. IRBs are responsible for ethical and scientific review of research and have authority to approve, require modifications to, or disapprove research.
Key stakeholders in clinical research include study sponsors, investigators and site personnel, monitors, institutional review boards (IRBs), study subjects, and regulators. Sponsors are responsible for the design and oversight of studies, including selecting investigators and monitoring sites. Investigators conduct the research and ensure ethical and safe treatment of subjects. IRBs and ethics committees review studies to protect subject safety and rights. Monitors verify compliance and safety on behalf of sponsors. Subjects participate in studies after providing informed consent. Regulators such as the FDA and CDSCO approve studies and ensure compliance.
Reporting to the IRB can mean navigating a maze of regulatory requirements. Staying current on what’s required – and what isn’t – is challenging. In this webinar, Quorum Review’s regulatory expert, Mitchell Parrish, JD, RAC, CIP, helps you concretely understand IRB reporting obligations.
This document discusses the role and functions of an Institutional Ethics Committee (IEC). The IEC is responsible for ensuring research involving human subjects is conducted ethically and protects participants' rights, safety, and well-being. The IEC reviews research proposals, consent forms, and other documents to evaluate risks and benefits to participants. It can approve research, approve with modifications, require resubmission with more information, or disapprove projects. The IEC also conducts continuing reviews of approved research. It is mandated by guidelines in India to ethically review all biomedical research involving human subjects.
The sponsor is responsible for initiating, managing, and financing clinical trials. This includes selecting investigators and sites, defining responsibilities, submitting documents for regulatory approval, monitoring safety and progress, ensuring proper labeling and storage of investigational products, auditing sites for compliance, and preparing and submitting clinical trial reports to regulatory authorities. The sponsor may delegate trial-related duties to third parties like CROs but retains ultimate responsibility for the trial.
The document discusses various topics related to medical ethics and research involving human subjects, including:
1. Historical events that shaped ethical guidelines like the Nuremberg Code and Declaration of Helsinki.
2. The structure and functions of Institutional Ethics Committees, including their role in reviewing research proposals and providing oversight.
3. Key principles of ethical research like informed consent, minimizing risks, and protecting participant privacy and welfare.
4. Issues around informed consent processes and the review of research by ethics committees.
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Dr B Naga Raju
Presentation on Roles and Responsibilities of sponsor in conducting clinical trials as per GCP-ICH for pursuing a subject in the course of PharmD programme under RGUHS
The document outlines the responsibilities of an investigator in clinical trials. An investigator is responsible for leading the clinical trial team and ensuring compliance with regulations. Key responsibilities include obtaining necessary approvals, ensuring safety of trial subjects, obtaining informed consent, accurately collecting and reporting data, and protecting subjects' rights and well-being. Maintaining high ethical standards in clinical trials is important to generate credible results and provide assurance to the public.
This document discusses clinical trials and their various components. It begins with an introduction to clinical trials, their purpose and importance. It then describes the key elements of a clinical trial protocol including the trial design, eligibility criteria, safety measures, statistical analysis plan and informed consent process. It also discusses the role and composition of the Institutional Review Board/Independent Ethics Committee which reviews and approves clinical trial protocols and procedures. Finally, it provides an overview of the four phases of clinical trials and concludes with references.
A standard for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials that provide assurance that the data and the reported results are credible (able to be believed), accurate and that the rights, integrity and confidentiality of trial subjects are protected.
Significance and formalities of ethics committees for Clinical ResearchRaktimavaDasSarkar
Clinical research plays a pivotal role in advancing medical knowledge, developing
new treatments, and improving patient care. However, with these advancements
come ethical responsibilities to ensure the safety, dignity, and rights of research
participants are protected.
This document outlines the roles and responsibilities of ethics committee (EC) members in reviewing clinical trial protocols. It describes the composition of ECs, which includes chairs, clinicians, scientists, legal experts, social scientists, philosophers, theologians, and lay people. The roles of EC members include scientifically and ethically reviewing protocols, informed consent documents, risks and benefits, qualifications, and providing ongoing trial oversight. The chair oversees meetings while the member secretary organizes documentation and communication. Together the multidisciplinary EC works to protect research participants.
The National Bioethics Committee (NBC) is an advisory body established by the Ministry of Health of Pakistan to deal with all aspects of bioethics in the health sector. The NBC aims to promote ethical health services, research, education, and medical journalism. It also oversees ethics review committees in various health organizations. The NBC upholds bioethical principles in healthcare and safeguards the rights and well-being of patients and research participants. It is responsible for the ethical review of research projects in Pakistan.
Institutional ethics committee : Roles and ResponsibilitiesDrSahilKumar
The document discusses the role and responsibilities of an Institutional Ethics Committee (IEC). The main points are:
1. An IEC is an independent body that reviews clinical trials and ensures the ethical treatment of human subjects. It evaluates protocols, informed consent forms, and other aspects of research proposals.
2. The IEC's main responsibilities are to protect participants, ensure universal ethical values are followed, and help develop research that meets local health needs.
3. The IEC reviews documents like protocols, consent forms, recruitment materials, safety information, and investigators' qualifications before research begins and conducts continuing annual reviews. It documents its approval, required modifications, or disapproval of proposed studies in writing.
The IRB/IEC is an independent body that reviews clinical trial protocols and protects participant rights and well-being. It consists of at least five qualified members from diverse backgrounds. The IRB/IEC reviews trials annually, ensures informed consent, and maintains documentation for regulatory review.
The document discusses the role and responsibilities of Institutional Review Boards (IRBs) and Independent Ethics Committees (IECs) in protecting human subjects in clinical research. IRBs/IECs review research protocols to evaluate scientific and ethical aspects and risks/benefits to participants. Their main purpose is to ensure the rights, safety, and well-being of trial subjects. IRBs/IECs must maintain documentation of their review procedures and activities.
The document discusses the basics of clinical research and clinical trials. It covers the key steps in drug discovery and development including target selection, validation, drug selection, optimization, pre-clinical and clinical testing. Clinical trials are systematic investigations in human subjects to evaluate safety and efficacy of new drugs, and are done in 4 phases. It takes approximately 10-12 years and $800 million to bring a new drug to market. Regulations, stakeholders, essential documents, and infrastructure requirements for clinical trials are also outlined.
Steps For Designing And Development Of Protocolpviral24
This document outlines the key sections and information to include when designing a clinical trial protocol. It discusses including background information on the investigational product, objectives, study design details, subject selection criteria, safety and efficacy assessments, data collection and management plans, statistical analysis methods, and other operational aspects like financing, publications, and records retention. The protocol is the detailed research plan that clinical trials are based on and it describes the rationale, structure, and procedures for the study.
Institutional ethics committee(IEC): A brief insight, by Rxvichu!!RxVichuZ
This is my 26th powerpoint.....its on INSTITUTIONAL ETHICS COMMITTEE(IEC) ...also known as RESEARCH and ETHICAL COMMITTEE(REC). It focusses on the general principles, that ought to be made, while selecting subjects for study.
Brief points, under specific headings, have been included.
Do go through this, and let me know your feedbacks.
Thank you!
Vishnu.
Suzanne Pozsonyi MedicReS World Congress 2013MedicReS
1. The document outlines the key study preparation and start up activities that are typically the responsibility of sponsors and CROs.
2. It discusses feasibility studies, site selection, pre-study visits, contracting, submitting documents to ethics committees, training, and initiation visits.
3. The purpose of these activities is to ensure clinical sites and investigators are properly qualified and prepared to conduct the study according to regulatory standards and the study protocol.
The document discusses the roles and responsibilities of ethics committees (ECs) or institutional review boards (IRBs). It states that ECs are independent bodies composed of medical, scientific, and non-scientific members who ensure the protection of human subjects in clinical trials. Their key responsibilities include reviewing and approving study protocols and informed consent documents. The document outlines that ECs should have a diverse membership including specialists in different areas like science, medicine, ethics, law, and lay persons. It explains the perspectives and expertise that different member types, such as basic scientists, legal experts, and social workers, provide to the EC. Finally, it states that the primary purpose of EC/IRB review is to assure the protection of subjects' rights
Clinical trial protocol, ammendments, Protocol deviations and violationsAmol Patil
This document provides guidelines for developing a clinical trial protocol including general information, background, aims and objectives, inclusion/exclusion criteria, study design, methodology, statistics, ethics, quality control, and protocol amendments. Key elements that must be addressed in the protocol are enumerated such as the research question, treatment characteristics, data collection and analysis, and legal responsibilities. Protocol deviations and violations that occur during the study are also discussed along with examples and regulatory requirements for reporting them. Adherence to good clinical practice and obtaining necessary approvals are emphasized.
Ethical committee-role, Principal InvestigatorGayathri Ravi
This document discusses ethics in research involving human subjects. It summarizes key landmark documents that guide ethical research, including the Nuremberg Code, Helsinki Declaration, and Belmont Report. It also describes the role and responsibilities of Institutional Review Boards (IRBs) in reviewing research proposals, ensuring risks are minimized and subjects' rights are protected, and providing ongoing oversight of approved studies. IRBs are responsible for ethical and scientific review of research and have authority to approve, require modifications to, or disapprove research.
Key stakeholders in clinical research include study sponsors, investigators and site personnel, monitors, institutional review boards (IRBs), study subjects, and regulators. Sponsors are responsible for the design and oversight of studies, including selecting investigators and monitoring sites. Investigators conduct the research and ensure ethical and safe treatment of subjects. IRBs and ethics committees review studies to protect subject safety and rights. Monitors verify compliance and safety on behalf of sponsors. Subjects participate in studies after providing informed consent. Regulators such as the FDA and CDSCO approve studies and ensure compliance.
Reporting to the IRB can mean navigating a maze of regulatory requirements. Staying current on what’s required – and what isn’t – is challenging. In this webinar, Quorum Review’s regulatory expert, Mitchell Parrish, JD, RAC, CIP, helps you concretely understand IRB reporting obligations.
This document discusses the role and functions of an Institutional Ethics Committee (IEC). The IEC is responsible for ensuring research involving human subjects is conducted ethically and protects participants' rights, safety, and well-being. The IEC reviews research proposals, consent forms, and other documents to evaluate risks and benefits to participants. It can approve research, approve with modifications, require resubmission with more information, or disapprove projects. The IEC also conducts continuing reviews of approved research. It is mandated by guidelines in India to ethically review all biomedical research involving human subjects.
The sponsor is responsible for initiating, managing, and financing clinical trials. This includes selecting investigators and sites, defining responsibilities, submitting documents for regulatory approval, monitoring safety and progress, ensuring proper labeling and storage of investigational products, auditing sites for compliance, and preparing and submitting clinical trial reports to regulatory authorities. The sponsor may delegate trial-related duties to third parties like CROs but retains ultimate responsibility for the trial.
The document discusses various topics related to medical ethics and research involving human subjects, including:
1. Historical events that shaped ethical guidelines like the Nuremberg Code and Declaration of Helsinki.
2. The structure and functions of Institutional Ethics Committees, including their role in reviewing research proposals and providing oversight.
3. Key principles of ethical research like informed consent, minimizing risks, and protecting participant privacy and welfare.
4. Issues around informed consent processes and the review of research by ethics committees.
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Dr B Naga Raju
Presentation on Roles and Responsibilities of sponsor in conducting clinical trials as per GCP-ICH for pursuing a subject in the course of PharmD programme under RGUHS
The document outlines the responsibilities of an investigator in clinical trials. An investigator is responsible for leading the clinical trial team and ensuring compliance with regulations. Key responsibilities include obtaining necessary approvals, ensuring safety of trial subjects, obtaining informed consent, accurately collecting and reporting data, and protecting subjects' rights and well-being. Maintaining high ethical standards in clinical trials is important to generate credible results and provide assurance to the public.
This document discusses clinical trials and their various components. It begins with an introduction to clinical trials, their purpose and importance. It then describes the key elements of a clinical trial protocol including the trial design, eligibility criteria, safety measures, statistical analysis plan and informed consent process. It also discusses the role and composition of the Institutional Review Board/Independent Ethics Committee which reviews and approves clinical trial protocols and procedures. Finally, it provides an overview of the four phases of clinical trials and concludes with references.
A standard for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials that provide assurance that the data and the reported results are credible (able to be believed), accurate and that the rights, integrity and confidentiality of trial subjects are protected.
Significance and formalities of ethics committees for Clinical ResearchRaktimavaDasSarkar
Clinical research plays a pivotal role in advancing medical knowledge, developing
new treatments, and improving patient care. However, with these advancements
come ethical responsibilities to ensure the safety, dignity, and rights of research
participants are protected.
The document provides an overview of the Indian Good Clinical Practice (GCP) guidelines. It notes that the guidelines were formulated by an expert committee in India to streamline clinical trials, while considering WHO, ICH, USFDA, and European GCP guidelines. The guidelines aim to ensure clinical studies are scientifically sound and ethically conducted. Key points covered include pre-requisites for studies, protocol requirements, informed consent processes, responsibilities of sponsors and investigators, and ethical review committee composition and roles.
The document summarizes key aspects of clinical trial protocols, including:
1) Protocols include sections like the title page, objectives, study design, safety reporting, and informed consent. Well-written protocols use clear, unambiguous language and define all abbreviations.
2) Eligibility criteria should be minimized but ensure scientific validity and safety. Criteria must be clearly defined and verifiable.
3) Institutional review boards (IRBs) are responsible for protecting human subjects. IRBs must have at least five members from varied backgrounds to review protocols and ensure ethical standards are followed.
Icmr ethical guidelines for biomedical research on human subjectSuraj Pamadi
This document outlines ethical guidelines for biomedical research involving human subjects presented by Suraj P.S. It discusses the ICMR Code established in 1949 and covers several topics including general principles of biomedical research, informed consent, composition and responsibilities of ethics committees, training requirements, and the review process. The key principles are that research must be directed to increasing knowledge, conducted in a way that respects human dignity, and subjected to evaluation at all stages.
This document describes the detailed information of clinical trial protocol and protocol design. The protocol includes the key information of study designs. This document is downloaded as a PDF and viewed online.
Assignment on Regulatory Prespectives of Clinical TrialsDeepak Kumar
Assignment on Origin and Principles of International Conference on Harmonization - Good Clinical Practice, (ICH-GCP) guidelines Ethical Committee- Institutional Review Board, Ethical Guidelines for Biomedical Research and Human Participant-Schedule Y, ICMR
This document outlines the roles and responsibilities of members of a clinical trial study team. It discusses the investigator who leads the trial, the coordinator who manages the day-to-day operations, the sponsor who provides funding and oversight, the monitor who ensures compliance, and the contract research organization which provides additional support services. For each role, the document describes the main responsibilities which include following regulatory standards, protecting participant safety, ensuring protocol adherence, and reporting requirements.
This document discusses ethics in clinical research. It begins by defining clinical research and ethics. There are four cardinal principles of ethical research: autonomy, beneficence, non-maleficence, and justice. There are also four pillars of ethical research: the principal investigator, ethics committee, institution, and regulator. Ethics in research is important to respect participants, ensure safety, and impose common standards. General principles of research ethics include essentiality of research, voluntary participation, non-exploitation of subjects, and minimizing risks while maximizing benefits. Ethics committees were created to protect participants and promote ethical policies.
This document discusses medical ethics in view of medical research. It begins by noting conflicts between various stakeholders in medical institutions. It then defines what ethics are and are not, establishing that ethics are based on moral principles of right and wrong. It discusses how medical ethics regulate professional conduct and relationships. The document outlines guidelines from organizations like WHO and ICMR for ethical research involving human subjects. It emphasizes informed consent and the role of institutional ethics committees in reviewing research proposals and ensuring ethical standards are followed. Throughout, it stresses applying ethical values with human perception in medical research.
Academic success and promotion in medicine largely depends on the quality and quantity of received grants. Grant money brings prestige and notoriety to the writer and his institution. However, writing a grant proposal can be a challenging task especially for the inexperienced researcher. As research budgets are being reduced by many funding agencies and more researches are competing for it, it is becoming increasingly important to be able to write a grant proposal of high quality.
The purpose of this article is to give the reader guidance on how to organize a research proposal in order maximize chances to obtain the desired funding. Key aspects will be highlighted and practical tips emphasized. This article will primarily focus on writing a grant for a clinical study.
Codes of ethics for biologist By Anita bibisamiiikhan5264
Codes of ethics for biologists outline ethical principles and standards to guide professional practice. They typically address research integrity, professional conduct, and respect for life and the environment. Key aspects often included are honest research, minimizing harm to living organisms, professional responsibility, environmental responsibility, informed consent, avoiding conflicts of interest, and public education. Institutional review boards ensure research involving humans meets ethical standards and protects participants.
INDIAN GCP GUIDELINE. for Regulatory affair 1st sem CRRsarwankumar4524
This document provides an overview of the Indian GCP guideline. It discusses key aspects of GCP including principles, the role of the independent ethics committee, informed consent process, responsibilities of sponsors, investigators and monitors, special considerations for vulnerable populations in clinical trials, and comparisons between Indian GCP and ICH GCP.
The document provides an overview of institutional ethics committees (IECs), including their evolution, composition, responsibilities, and functions. Key points include:
- IECs were established to safeguard human subjects in clinical research following unethical studies in the 1940s-1970s.
- An IEC typically has 7-15 multidisciplinary members including medical, legal, and layperson representatives.
- Responsibilities include reviewing research protocols, providing oversight of ongoing studies, and ensuring participant safety and consent.
- Functions involve initial and continuing review of research, approving protocols, and maintaining documentation of IEC activities.
This document summarizes the key components of a clinical trial protocol. It discusses the types of clinical trials, phases of clinical trials, and the typical sections included in a protocol such as the title, objectives, study design, study population criteria, safety and efficacy assessments, statistics, and quality control plans. Protocols provide a formal design and plan for how a clinical trial will be conducted, managed, and reported.
The document outlines the key roles and responsibilities of an investigator in clinical research. It discusses that the investigator is responsible for ensuring ethical conduct of the research study, obtaining informed consent, overseeing all aspects of the clinical trial from design to results. The investigator must qualify by training and experience, submit required documents to the IRB for review, monitor the trial, report adverse events, interact with subjects, and assist in audits. The investigator plays a critical role in successfully meeting research expectations and regulatory requirements.
Phytochemical screening and evaluation of aphrodisiac and antihyperlipidemic ...Srota Dawn
This document discusses a dissertation submitted to Vels University in partial fulfillment of the requirements for a Master of Pharmacy degree. The dissertation involves phytochemical screening and evaluation of the aphrodisiac and antihyperlipidemic activities of a polyherbal extract containing Daucus carota sativus seeds, Musa paradisiaca sapientum stem, and Cucumis melo peel. It provides background on the plants and certificates from the dissertation guide and university directors.
This document summarizes acute and chronic inflammation. Acute inflammation occurs within minutes to days and is characterized by fluid and protein exudation and the presence of polymorphonuclear cells (PMNs). Chronic inflammation lasts weeks to years and is characterized by lymphocytes and macrophages. Both types of inflammation aim to eliminate pathogens and promote repair. A variety of inflammatory mediators are involved, including histamine, bradykinin, prostaglandins, leukotrienes, and cytokines, which cause increased vascular permeability, vasodilation, and recruit immune cells.
buchanania lanzan hepatocarcinoma presentationSrota Dawn
1) The study evaluated the anticancer potential of the ethanolic extract of Buchanania lanzan leaves against diethylnitrosamine (DEN)-induced hepatocellular carcinoma in rats.
2) Administration of the extract at doses of 200 mg/kg and 400 mg/kg reduced serum markers of liver damage and oxidative stress in DEN-treated rats compared to the DEN alone group.
3) Preliminary phytochemical analysis revealed the presence of flavonoids, alkaloids, gallic acid and glycosides in the extract, which may contribute to its chemo preventive effects against liver cancer.
Differential scanning calorimetry (DSC) is a thermoanalytical technique used to analyze characteristics of polymers and other materials. DSC measures heat flow into and out of a sample as it is heated, cooled, or held isothermally. By monitoring the heat difference between a sample and an inert reference, DSC can detect physical and chemical changes associated with phase transitions, such as glass transitions, melting points, and crystallization events. The document discusses the principles, instrumentation, applications, and interpretation of DSC analysis for studying various material properties and transitions.
Histamine and serotonin ppt by srota dawnSrota Dawn
Histamine and serotonin are important autacoids that act as local hormones or mediators.
Histamine is synthesized from the amino acid histidine and stored in mast cells. It binds to H1, H2, and H3 receptors and causes various effects including vasodilation, increased vascular permeability, bronchoconstriction, and gastric acid secretion. Serotonin is found primarily in enterochromaffin cells and platelets. It acts as a neurotransmitter and vasoconstrictor and is involved in platelet aggregation, nausea/vomiting, and appetite regulation.
First and second generation antihistamines antagonize H1 receptors and are used for allergies, while H2 receptor antagon
introduction Bio ethics and preclinical and clinical trial by srota dawnSrota Dawn
Bioethics involves studying the ethical implications of biological discoveries and medical advances. It examines what decisions are morally right regarding issues in fields like genetics and drug research. Regulations like the Hippocratic Oath and more modern frameworks provide guidance. Preclinical research ethics evaluates a potential drug's effects through non-human animal tests before human trials. These aim to reduce animal use, refine methods, and replace animals when possible. Clinical trials in humans have phases to assess safety, efficacy, and long-term effects compared to existing treatments. Regulations like CPCSEA in India oversee animal welfare in research.
Contact dermatitis can be caused by allergic reactions (allergic contact dermatitis) or irritants (irritant contact dermatitis). Allergic contact dermatitis is a type IV delayed hypersensitivity reaction that occurs when a sensitized individual is re-exposed to an allergen. It accounts for about 20% of contact dermatitis cases. Patch testing is needed to identify the specific allergen causing allergic contact dermatitis. Irritant contact dermatitis results from direct skin damage caused by chemicals, metals, fabrics, or other irritating substances. Avoiding the irritating or allergenic substance is the primary treatment approach for both types of contact dermatitis.
UV-visible spectroscopy involves using ultraviolet or visible light to analyze compounds. When molecules absorb UV or visible light, their electrons are excited from the ground state to a higher energy state. There are several types of electronic transitions that can occur: n→π*, π→π*, n→σ*, and σ→σ*. The energy required for these transitions increases in the order n→π* < π→π* < n→σ* < σ→σ*. Solvents play an important role, as solvent peaks can obscure sample peaks, and polar solvents can cause bathochromic or blue shifts in transition wavelengths.
Gout is a metabolic disorder caused by elevated levels of uric acid in the blood (hyperuricemia). Uric acid crystallizes and deposits in joints, causing sudden and severe attacks of arthritis. Gout can be primary, due to overproduction of uric acid, or secondary, due to other conditions that reduce excretion or increase production of uric acid. Treatment involves medications to reduce uric acid levels such as allopurinol and probenecid, as well as lifestyle changes like a low-purine diet and increased fluid intake. Nonsteroidal anti-inflammatory drugs and corticosteroids are used to treat acute gout attacks and bring down joint inflammation.
PPT ON PHARMACOKINETIC DRUG interaction BY SROTA DAWNSrota Dawn
The document discusses pharmacokinetic drug interactions, which occur when one drug alters the effects of another drug by changing its concentration at the target site. It identifies several mechanisms for these interactions, including changes to absorption, distribution, metabolism, and excretion of the drug. Metabolism is a major mechanism, and can involve induction or inhibition of the enzymes responsible for drug metabolism. This can increase or decrease the concentration of the affected drug. Factors like multiple drug therapy, multiple prescribers, and patient non-compliance increase risk of interactions. Proper monitoring and awareness of possible interactions can help prevent negative outcomes.
This document provides information on hernias, including what they are, types of hernias, signs and symptoms, risk factors, and treatment options. The main types of hernias discussed are inguinal, hiatal, femoral, umbilical, and incisional hernias. Hernias occur when an organ or fatty tissue protrudes through a weakness in the abdominal wall. While usually harmless, hernias can become strangulated and cut off blood flow, which is a surgical emergency. Surgery is the primary treatment for hernias to prevent complications, with options like mesh plugs and laparoscopic repair.
Srota Dawn synthesized possible anticonvulsant drugs under the supervision of Prof. Dhananjay Pal to fulfill the requirements for a B.Pharm degree. The project involved synthesizing butyl phthalimide through a two-step process of first preparing phthalic anhydride from phthalic acid, then reacting the phthalic anhydride with butyl amine. The crude product was recrystallized multiple times and its melting point was found to match that of butyl phthalimide, indicating the target compound was successfully synthesized. The goal was to evaluate the synthesized compound for anticonvulsant activity.
This document discusses different classes of diuretic drugs based on their site of action in the nephron. It defines diuretics as drugs that increase urine output and lists the four major sites where diuretics act - the proximal convoluted tubule (PCT), the thick ascending limb of Henle's loop, the distal convoluted tubule (DCT), and the collecting tubule. It provides examples of diuretic drugs that act at each site such as carbonic anhydrase inhibitors at site 1, loop diuretics at site 2, thiazide diuretics at site 3, and potassium-sparing diuretics at site 4. It also briefly discusses the mechanisms of action, effects
This document summarizes methods for screening sympathomimetic and sympatholytic drugs. Sympathomimetics mimic epinephrine and stimulate the sympathetic nervous system, while sympatholytics block these effects. Screening methods include in vivo tests using cat spleens or measuring nictitating membrane prolapse in cats. In vitro tests involve measuring contractions of rabbit pulmonary arteries, rat vas deferens, or cat spleen strips in response to drugs. These assays allow evaluating sympatholytic potency by assessing the ability of test drugs to reduce contractions caused by agonists like epinephrine and norepinephrine.
The document discusses different types of CNS stimulants including analeptics, methylxanthines, central sympathomimetic agents, and antidepressants. It notes that traditional analeptics like picrotoxin and PTZ are potent but non-selective and now obsolete, but used for research. Newer selective agents like modafinil and doxapram are used to treat conditions like narcolepsy and respiratory issues.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) CurriculumMJDuyan
(𝐓𝐋𝐄 𝟏𝟎𝟎) (𝐋𝐞𝐬𝐬𝐨𝐧 𝟏)-𝐏𝐫𝐞𝐥𝐢𝐦𝐬
𝐃𝐢𝐬𝐜𝐮𝐬𝐬 𝐭𝐡𝐞 𝐄𝐏𝐏 𝐂𝐮𝐫𝐫𝐢𝐜𝐮𝐥𝐮𝐦 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐡𝐢𝐥𝐢𝐩𝐩𝐢𝐧𝐞𝐬:
- Understand the goals and objectives of the Edukasyong Pantahanan at Pangkabuhayan (EPP) curriculum, recognizing its importance in fostering practical life skills and values among students. Students will also be able to identify the key components and subjects covered, such as agriculture, home economics, industrial arts, and information and communication technology.
𝐄𝐱𝐩𝐥𝐚𝐢𝐧 𝐭𝐡𝐞 𝐍𝐚𝐭𝐮𝐫𝐞 𝐚𝐧𝐝 𝐒𝐜𝐨𝐩𝐞 𝐨𝐟 𝐚𝐧 𝐄𝐧𝐭𝐫𝐞𝐩𝐫𝐞𝐧𝐞𝐮𝐫:
-Define entrepreneurship, distinguishing it from general business activities by emphasizing its focus on innovation, risk-taking, and value creation. Students will describe the characteristics and traits of successful entrepreneurs, including their roles and responsibilities, and discuss the broader economic and social impacts of entrepreneurial activities on both local and global scales.
Leveraging Generative AI to Drive Nonprofit InnovationTechSoup
In this webinar, participants learned how to utilize Generative AI to streamline operations and elevate member engagement. Amazon Web Service experts provided a customer specific use cases and dived into low/no-code tools that are quick and easy to deploy through Amazon Web Service (AWS.)
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
Communicating effectively and consistently with students can help them feel at ease during their learning experience and provide the instructor with a communication trail to track the course's progress. This workshop will take you through constructing an engaging course container to facilitate effective communication.
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxEduSkills OECD
Iván Bornacelly, Policy Analyst at the OECD Centre for Skills, OECD, presents at the webinar 'Tackling job market gaps with a skills-first approach' on 12 June 2024
2. 1.
• Ethical principles
2.
• Institutional Review Board
3.
• Standard Operating Procedures
(SOP) for Institutional Ethics
Committee for Human Research
4
• Institutional ethical
committee
5.
• ICMR
3. 1. Honesty:
Honestly report data, results,
methods and procedures and
publication status. Do not fabricate,
falsify or misinterpret data.
2. Objectivity :
Strike to avoid bias in
experimental design, data analysis,
data interpretation etc.
GENERAL BASIC
PRINCIPALS OF ETHICS
4. 3. Integrity:
Keep your promises and agreements,
act with sincerity, strive for consistency of
thought and action.
4. Carefulness:
Avoid careless errors and negligence
. Carefully and critically examine your own
work. Keep good record of research
activities such as data collection, research
design and correspondence with agencies
or journals
5. Openness:
5. 6. Respect for intellectual property:
i) Honor patents, copyright and other
forms of intellectual property.
ii) Do not use unpublished data ,
methods or results without permission
iii) Never plagiarizes
7. Confidentiality:
Protect confidential communication such
as paper or grants submitted for
publication, personnel records, trade or
military secrets and patient records
6. 8. Respect for colleagues:
Respect your colleagues and treat
them fairly
9. Non discrimination:
Avoid discrimination against
colleagues or students on the basis of
sex, race, or other factors that are not
related to their scientific competence
and integrity
10. Social Responsibility:
7. INSTITUTIONAL REVIEW
BOARD
INSTITUTIONAL REVIEW BOARD
(IRB), is also known as
an Independent ethics committee
or ethical review board.
It is a committee that has been
formally designated to approve,
monitor, and review biomedical and
behavioural research involving
humans
8. Need of IRB
IRBs are most commonly used for studies
in the fields of health and the social
sciences, including anthropology,
sociology, and psychology
The need of IRBs is to protect human
subjects from physical or psychological
harm.
IRBs attempt to ensure protection of
subjects by reviewing research protocols
9. Role of IRB
IRB will review and approve all types of
research proposals involving human
participants with a view to safeguard the
dignity, rights, safety and well being of all
actual and potential research participants.
it will look into the aspects of informed
consent process, risk benefit ratio,
distribution of burden and benefit and
provisions for appropriate compensations
wherever required.
10. Role of IRB
It will review the proposals before start of
the study as well as monitor the research
throughout the study until and after
completion of the study through
appropriate well documented procedures.
It is mandatory that IRB/IECs will be to
review all research projects involving
human subjects to be conducted at the
Institute, irrespective of the funding
agency. The role of IEC can be modified
according to the requirement of each
Institute
11. Standard Operating Procedures (SOP) for
Institutional Ethics Committee for Human
Research
Objective:
The objective of this SOP is to contribute to the
effective functioning of the Institutional Ethics
Committee (IEC) so that a quality and consistent
ethical review mechanism for health and
biomedical research is put in place for all proposals
dealt by the Committee as prescribed by the Ethical
guidelines for biomedical research on human
subjects of ICMR.
12. Documentation:
For a thorough and complete review, all research
proposals should be submitted
with the following documents :
1. Name of the applicant with designation
2. Name of the Institute/ Hospital / Field area
where research will be conducted.
3. Approval of the Head of the Department /
Institution
4. Protocol of the proposed research
5. Ethical issues in the study and plans to address
these issues.
6. Proposal should be submitted with all relevant
enclosures like pro formae, case report forms,
questionnaires, follow - up cards, etc.
7. Informed consent process, including patient
13. 8. For any drug / device trial, all relevant pre-
clinical animal data and clinical trial data from
other centres within the country / countries, if
available.
9. Curriculum vitae of all the investigators with
relevant publications in last five years.
10. Any regulatory clearances required.
11. Source of funding and financial requirements
for the project.
12. Other financial issues including those related
to insurance
13. An agreement to report only Serious Adverse
Events (SAE) to IEC.
14. Statement of conflicts of interest, if any.
15. Agreement to comply with the relevant national
and applicable international Guidelines.
14. 16. A statement describing any compensation for
study participation (including expenses and access
to medical care) to be given to research
participants; a description of the arrangements for
indemnity, if applicable (in study-related injuries); a
description of the arrangements for insurance
coverage for research participants, if applicable; all
significant previous decisions(e.g., those leading to
a negative decision or modified protocol) by other
ECs or regulatory authorities for the proposed
study (whether in the same location or elsewhere)
and an indication of the modification(s) to the
protocol made on that account. The reasons for
negative decisions should be provided.
17. Plans for publication of results – positive or
15. Institutional ethical
committee(ICE)Authority under which IEC is
constituted:
The Institutional Head constitutes the
IEC.
•The duration of appointment is initially for a
period of 2-3 years
Members of ICE:
1. Chairperson(Committee should preferably be
from outside the Institution and not head of the
same Institution to maintain the independence of
the Committee)
2. 1-2 basic medical scientists.
16. 5. One social scientist / representative of non-
governmental voluntary agency
6. One philosopher / ethicist /
theologian(academic discipline)
7. One lay person from the community
8. Member-Secretary(generally belongs to the
same Institution should conduct the business of the
Committee.)
Members of ICE:
17. Element of review
a. Scientific design and conduct of the study.
b. Approval of appropriate scientific review
committees.
c. Examination of predictable risks/harms.
d. Examination of potential benefits.
e. Procedure for selection of subjects in
methodology including inclusion/ exclusion,
withdrawal criteria and other issues like
advertisement details.
f. Management of research related injuries,
adverse events.
g. Compensation provisions.
h. Justification for placebo in control arm, if any.
18. i . Availability of products after the study, if
applicable.
j. Patient information sheet and informed
consent form in local language.
k. Protection of privacy and confidentiality.
l. Involvement of the community, wherever
necessary.
m. Plans for data analysis and reporting
n. Adherence to all regulatory requirements and
applicable guidelines
o. Competence of investigators, research and
supporting staff
p. Facilities and infrastructure of study sites
q. Criteria for withdrawal of patients,
suspending or terminating the study
19. ICMR
Indian Council of Medical
Research(ICMR) is one of the oldest and
largest medical research bodies in
the world.
History of ICMR
In 1911, the Government of India set up
the Indian Research Fund
Association (IRFA) with the specific
objective of sponsoring and
coordinating medical research in
20. After independence, several important
changes were made in the organisation and the
activities of the IRFA. It was redesignated the
Indian Council of Medical
Research (ICMR) in 1949,
with considerably expanded scope of functions.
The ICMR is funded by
the Government of India through the
Ministry of Health and Family Welfare.